Coherus Oncology, Inc.
CHRSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Coherus Oncology, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 14 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 9, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| SIMPLEX TRADING, LLC | 2026-03-31 | 44,402 | $75K | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 69,809 | $118K | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 111,791 | $189K | SEC filing |
| Larson Financial Group LLC | 2026-03-31 | 40 | $68 | SEC filing |
| Stratos Wealth Partners, LTD. | 2026-03-31 | 16,131 | $27.3K | SEC filing |
| Clearstead Advisors, LLC | 2026-03-31 | 266 | $449 | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 38,639 | $65.3K | SEC filing |
| Cerity Partners LLC | 2026-03-31 | 35,968 | $60.8K | SEC filing |
| Propel Bio Management, LLC | 2026-03-31 | 1,420,550 | $2.41M | SEC filing |
| Sunbelt Securities, Inc. | 2026-03-31 | 16 | $27 | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 1,155,901 | $1.95M | SEC filing |
| CAPTRUST FINANCIAL ADVISORS | 2026-03-31 | 16,994 | $28.7K | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 20,593 | $34.8K | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 14,230 | $24K | SEC filing |
| Steigerwald, Gordon & Koch Inc. | 2026-03-31 | 1,000 | $1.69K | SEC filing |
| Avion Wealth | 2026-03-31 | 660 | Not shown | SEC filing |
| NEUBERGER BERMAN GROUP LLC | 2026-03-31 | 14,675 | $24.8K | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 40,494 | $68.4K | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 32,797 | Not shown | SEC filing |
| VICTORY CAPITAL MANAGEMENT INC | 2026-03-31 | 14,118 | $23.9K | SEC filing |
- Each value is checked against Coherus Oncology, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Coherus Oncology, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Coherus Oncology, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-05-23 · Wahlstrom Mats: Larger than 20 of the 22 other insider sales of Common Stock on file. SEC filing
- 2023-11-22 · Lanfear Dennis M: Larger than all 22 other insider sales of Common Stock on file. SEC filing
- 2021-03-09 · Vexler Vladimir: Larger than 21 of the 22 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-23 | Wahlstrom Mats · Director | Common Stock | S — Open market or private sale | −99,988 | 0.74 | SEC filing |
| 2023-11-22 | Lanfear Dennis M · President & CEO | Common Stock | S — Open market or private sale | −223,100 | 2.02 | SEC filing |
| 2021-10-15 | Stilwell McDavid · Chief Financial Officer | Common Stock | S — Open market or private sale | −3,507 | 16.80 | SEC filing |
| 2021-09-29 | HEALY JAMES · Director | Common Stock, $0.0001 par value | S — Open market or private sale | −286,076 | 16.12 | SEC filing |
| 2021-09-28 | HEALY JAMES · Director | Common Stock, $0.0001 par value | S — Open market or private sale | −48,329 | 17.17 | SEC filing |
| 2021-09-27 | HEALY JAMES · Director | Common Stock, $0.0001 par value | S — Open market or private sale | −100,150 | 18.06 | SEC filing |
| 2021-06-09 | Stilwell McDavid · Chief Financial Officer | Common Stock | P — Open market or private purchase | +3,700 | 13.42 | SEC filing |
| 2021-06-08 | Lanfear Dennis M · President & CEO | Common Stock | S — Open market or private sale | −31,054 | 13.56 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-05 | Satvat Ali J. · Director | Common Stock | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-05 | O'Donnell-Tormey Jill · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +60,000 | SEC filing |
| 2026-06-05 | Wahlstrom Mats · Director | Common Stock | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-05 | Newton Charles W. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +60,000 | SEC filing |
| 2026-06-05 | Newcomer Lee Nisley · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +60,000 | SEC filing |
| 2026-06-05 | Wahlstrom Mats · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +60,000 | SEC filing |
| 2026-06-05 | Newcomer Lee Nisley · Director | Common Stock | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-05 | Newton Charles W. · Director | Common Stock | A — Grant, award, or other acquisition | +30,000 | SEC filing |
Showing 8 of 34 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-29 | McMichael Bryan J · Chief Financial Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −100,000 | SEC filing |
| 2026-05-29 | McMichael Bryan J · Chief Financial Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −30,000 | SEC filing |
| 2026-05-29 | McMichael Bryan J · Chief Financial Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −25,000 | SEC filing |
| 2026-05-29 | Lanfear Dennis M · President & CEO | Stock Option (Right to Buy) | D — Disposition to the issuer | −200,000 | SEC filing |
| 2026-05-29 | Lanfear Dennis M · President & CEO | Stock Option (Right to Buy) | D — Disposition to the issuer | −400,000 | SEC filing |
| 2026-05-29 | McMichael Bryan J · Chief Financial Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −15,000 | SEC filing |
| 2026-05-29 | Lanfear Dennis M · President & CEO | Stock Option (Right to Buy) | D — Disposition to the issuer | −402,500 | SEC filing |
| 2026-05-29 | Lanfear Dennis M · President & CEO | Stock Option (Right to Buy) | D — Disposition to the issuer | −225,000 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.